| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PTC THERAPEUTICS, INC. | Director | Common Stock | 18.5K | $835K | $45.16 | Jan 3, 2025 | Direct |
| NEXGEL, INC. | Director | Common Stock | 107K | $293K | $2.75 | Nov 20, 2024 | Direct |
| PTC THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 8.8K | $238K | $27.05 | Jan 3, 2025 | Direct |
| NexImmune, Inc. | Executive VP of Research & Dev | Stock Option (Right to Buy) | 80.1K | Apr 5, 2022 | Direct | ||
| NEXGEL, INC. | Director | Stock Option (Right to Buy) | 25K | Sep 13, 2024 | Direct | ||
| SOLIGENIX, INC. | Director | Stock Option (Right to Buy) | 8.65K | Dec 12, 2024 | Direct | ||
| NEXGEL, INC. | Director | Warrant to Purchase Common Stock | 1.82K | Nov 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PTCT | PTC THERAPEUTICS, INC. | Jan 3, 2025 | 2 | $0 | 4 | Jan 7, 2025 | Director |
| SNGX | SOLIGENIX, INC. | Dec 12, 2024 | 1 | $0 | 4 | Dec 13, 2024 | Director |
| PTCT | PTC THERAPEUTICS, INC. | Dec 2, 2024 | 9 | -$254K | 4 | Dec 4, 2024 | Director |
| NXGL | NEXGEL, INC. | Nov 20, 2024 | 2 | $10K | 4 | Nov 22, 2024 | Director |
| NXGL | NEXGEL, INC. | Sep 13, 2024 | 1 | $0 | 4 | Sep 17, 2024 | Director |
| NXGL | NEXGEL, INC. | Aug 23, 2024 | 2 | $25K | 4 | Aug 27, 2024 | Director |
| PTCT | PTC THERAPEUTICS, INC. | May 22, 2024 | 3 | -$236K | 4 | May 24, 2024 | Director |
| PTCT | PTC THERAPEUTICS, INC. | Feb 15, 2024 | 2 | $0 | 4 | Feb 16, 2024 | Director |
| SNGX | SOLIGENIX, INC. | Dec 15, 2023 | 1 | $0 | 4 | Dec 15, 2023 | Director |
| NXGL | NEXGEL, INC. | Aug 17, 2023 | 1 | $0 | 4 | Aug 21, 2023 | Director |
| NXGL | NEXGEL, INC. | May 26, 2023 | 1 | $11.7K | 4 | May 30, 2023 | Director |
| PTCT | PTC THERAPEUTICS, INC. | Jan 5, 2023 | 2 | $0 | 4 | Jan 9, 2023 | Director |
| SNGX | SOLIGENIX, INC. | Nov 17, 2022 | 1 | $0 | 4 | Nov 21, 2022 | Director |
| NEXI | NexImmune, Inc. | Apr 5, 2022 | 1 | $0 | 4 | Apr 7, 2022 | Executive VP of Research & Dev |
| NXGL | NEXGEL, INC. | Mar 25, 2022 | 1 | $10K | 4 | Mar 28, 2022 | Director |
| PTCT | PTC THERAPEUTICS, INC. | Jan 7, 2022 | 2 | $0 | 4 | Jan 11, 2022 | Director |
| NXGL | NEXGEL, INC. | Dec 27, 2021 | 2 | $50K | 4 | Jan 3, 2022 | Director |
| SNGX | SOLIGENIX, INC. | Sep 23, 2021 | 1 | $0 | 4 | Sep 24, 2021 | Director |
| SNGX | SOLIGENIX, INC. | May 14, 2021 | 2 | -$37 | 4 | May 18, 2021 | Director |